The global anti-aging drugs marketis expected to grow at a CAGR of more than 8% from 2017-2021, according to a new market research report by Technavio.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171207005403/en/
Technavio has published a new market research report on the global anti-aging drugs market from 2017-2021. (Graphic: Business Wire)
Global anti-aging drugs market segmentation by route of administration and geography
Technavio's report on the global anti-aging drugs marketanalyses the business dimensions and presents a comprehensive breakdown in terms of market segmentation by route of administration which injectible, oral, and topical. As projected in 2016, over 58% of the market share originated from injectibles.
Based on geography, the global anti-aging drugs markethas been segmented into the Americas, EMEA, and APAC. As of 2016, 49% of the market share came from the Americas.
"The Americas held the largest share of the global anti-aging drugs market in 2016, primarily due to huge investment in the healthcare sector in the US. Huge investment in the pharmaceutical industry, the presence of pharmaceutical giants in the region, and the rising geriatric population are some of the factors accounting for the dominance of the US in the region as well as globally," says Sapna Jha, a lead analyst at Technavio for infectious and rare diseasesresearch.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free
Anti-aging drugs market: competitive vendor landscape
The global anti-aging drugs marketconsists of a large number of players dealing in various segments such as injectable drugs, HRT, topical pharmaceutical agents, etc. The market is dominated by pharmaceutical giants such as Allergan, Galderma, Sanofi, and Merz Pharma. Several other market players are emerging in the market with their novel therapies. The development of drugs for the treatment of growing spasticity disorders such as wrinkles will increase the competition among vendors.
Looking for more information on this market? Request a free sample report
Technavio's sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Other topics covered in the report:
Market drivers:
- Rising geriatric population
- Rising demand for non-invasive treatment solutions in cosmetology
Market challenges:
- Stringent government regulations
- High cost of products
Market trends:
- Technological advancements
- Advent of novel drugs
Get a sample copy of the global anti-aging drugs market report free of cost
Access Technavio's continuously growing infectious and rare diseases research library and find expert analysis on hundreds of markets.
About Technavio
Technaviois a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005403/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
